You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
Title |
Infection with hepatitis B and C virus in Europe: a systematic review of prevalence and cost-effectiveness of screening
|
---|---|
Published in |
BMC Infectious Diseases, April 2013
|
DOI | 10.1186/1471-2334-13-181 |
Pubmed ID | |
Authors |
Susan JM Hahné, Irene K Veldhuijzen, Lucas Wiessing, Tek-Ang Lim, Mika Salminen, Marita van de Laar |
Abstract |
Treatment for chronic hepatitis B virus (HBV) and hepatitis C virus (HCV) infection is improving but not benefiting individuals unaware to be infected. To inform screening policies we assessed (1) the hepatitis B surface antigen (HBsAg) and anti-hepatitis C virus antibody (anti-HCV-Ab) prevalence for 34 European countries; and (2) the cost-effectiveness of screening for chronic HBV and HCV infection. |
X Demographics
The data shown below were collected from the profiles of 14 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 4 | 29% |
United Kingdom | 2 | 14% |
South Africa | 1 | 7% |
Spain | 1 | 7% |
Italy | 1 | 7% |
Unknown | 5 | 36% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 10 | 71% |
Scientists | 3 | 21% |
Science communicators (journalists, bloggers, editors) | 1 | 7% |
Mendeley readers
The data shown below were compiled from readership statistics for 285 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Peru | 2 | <1% |
Brazil | 1 | <1% |
Switzerland | 1 | <1% |
Egypt | 1 | <1% |
Spain | 1 | <1% |
Unknown | 279 | 98% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 49 | 17% |
Researcher | 42 | 15% |
Student > Bachelor | 30 | 11% |
Student > Ph. D. Student | 26 | 9% |
Other | 22 | 8% |
Other | 48 | 17% |
Unknown | 68 | 24% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 119 | 42% |
Nursing and Health Professions | 22 | 8% |
Agricultural and Biological Sciences | 15 | 5% |
Social Sciences | 13 | 5% |
Biochemistry, Genetics and Molecular Biology | 10 | 4% |
Other | 31 | 11% |
Unknown | 75 | 26% |
Attention Score in Context
This research output has an Altmetric Attention Score of 23. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 10 August 2022.
All research outputs
#1,616,330
of 25,292,378 outputs
Outputs from BMC Infectious Diseases
#395
of 8,527 outputs
Outputs of similar age
#12,441
of 203,356 outputs
Outputs of similar age from BMC Infectious Diseases
#4
of 141 outputs
Altmetric has tracked 25,292,378 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 93rd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 8,527 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.7. This one has done particularly well, scoring higher than 95% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 203,356 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 93% of its contemporaries.
We're also able to compare this research output to 141 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 97% of its contemporaries.